Paraneoplastic Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Early Immunotherapy With Intravenous Immunoglobulin, Cyclophosphamide and Methylprednisolone in Patients With Anti-Hu-associated Paraneoplastic Sensory Neuronopathy
Conditions: Paraneoplastic Sensory Neuronopathy Interventions: Drug: Immunoglobulins IV (CLAYRIG); Drug: Cyclophosphamide IV; Drug: Methylprednisolone IV Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials

Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study
Conditions: Cancer-related Stroke; Paraneoplastic Coagulopathy; Occult Cancer; Ischemic Stroke; Embolic Stroke of Undetermined Source; D-dimer Sponsors: Insel Gruppe AG, University Hospital Bern Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials

Paraneoplastic Syndrome in Hepatocellular Carcinoma Patients
Condition: Hepatocellular Carcinoma Patients Intervention: Diagnostic Test: Triphasic C.T abdomen and pelvis Sponsor: Sohag University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes
Conditions: Autoimmune Encephalitis; Paraneoplastic Neurological Syndrome Intervention: Biological: Genetic and immunology tests Sponsor: Hospices Civils de Lyon Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2023 Category: Research Source Type: clinical trials